African Pharmaceutical Regulatory Intelligence
VALSARTAN
182 registrations across 13 African markets— 120 active
Markets with VALSARTAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VASAR TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Apr 2031 |
| Zomevak 80 tablets Tablet Uncoated | 🇿🇲Zambia | Sandoz SA (PTY) LTD | active | Dec 2029 |
| Zomevak 160 tablets Tablet Uncoated | 🇿🇲Zambia | Sandoz SA (PTY) LTD | active | Dec 2029 |
| Nucard 80 mg Tablet** Tablet | 🇳🇬Nigeria | Fensyl MHP Consulting Limited | active | Dec 2029 |
| Nucard 160 mg Tablet** Tablet | 🇳🇬Nigeria | Fensyl MHP Consulting Limited | active | Sept 2029 |
| VALAZYD CO 160/125 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Sept 2029 |
| VALSARTAN HYDROCHLOROTHIAZIDE 160/25 ZYDUS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Sept 2029 |
| VALSARTAN HYDROCHLOROTHIAZIDE 160/12,5 ZYDUS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Sept 2029 |
| VALSARTAN HYDROCHLOROTHIAZIDE 80/12,5 ZYDUS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Sept 2029 |
| VALAZYD CO 160/25 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Sept 2029 |
| VALAZYD CO 80/12,5 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Sept 2029 |
| Valsartan 80 mg Tablets_ Tablet | 🇳🇬Nigeria | Society for Family Health | active | Jun 2029 |
| Valsartan 80 mg Tablet Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2029 |
| Valsartan 160 mg Tablet Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2029 |
| RASLATAV 80 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2029 |
| RASLATAV 40 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2029 |
| RASLATAV 160 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2029 |
| RASLATAV 320 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Apr 2029 |
| Valsartan 160 mg Tablets Tablet | 🇳🇬Nigeria | Society for Family Health | active | Mar 2029 |
| VALAZYD 80 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jul 2028 |
| VALAZYD 40 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jul 2028 |
| VALAQUIL 160 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jul 2028 |
| VALAQUIL 80 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jul 2028 |
| VALAZYD 160 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jul 2028 |
| VALAQUIL 40 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jul 2028 |
| Carvals 80** Tablet | 🇳🇬Nigeria | Ranbaxy Nigeria Limited | active | Apr 2028 |
| Carvals 160 Tablets** Tablet | 🇳🇬Nigeria | Ranbaxy Nigeria Limited | active | Mar 2028 |
| VALSARTAN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS SOUTH AFRICA (PTY) LTD | active | Dec 2027 |
| MEDI-VALSARTAN TABLET; ORAL | 🇿🇼Zimbabwe | NEW AVAKASH INTERNATIONAL | active | Dec 2027 |
| MEDI-VALSARTAN TABLET; ORAL | 🇿🇼Zimbabwe | NEW AVAKASH INTERNATIONAL | active | Dec 2027 |
| TAREG TABLET; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMA STEIN AG | active | Dec 2027 |
| VALSARTAN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS SOUTH AFRICA (PTY) LTD | active | Dec 2027 |
| VALSAR 160 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| SKY PHARM-VALSARTAN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ADVENTURA INVESTMENTS LIMITED | active | Dec 2027 |
| SKY PHARM- VALSARTAN TABLET, COATED; ORAL | 🇿🇼Zimbabwe | ADVENTURA INVESTMENTS LIMITED | active | Dec 2027 |
| TAREG TABLET, COATED; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMA STEIN AG | active | Dec 2027 |
| CARDISAR HT 80/12.5 (Valsartan and… Tablet | 🇰🇪Kenya | Mylan Pharmaceuticals Private Limited | active | Aug 2027 |
| Valsartil 80 mg Tablets Tablet | 🇳🇬Nigeria | Bio-Generics Nigeria Limited | active | Dec 2026 |
| Valsar-Denk-80** Tablet | 🇳🇬Nigeria | Assene-Laborex Limited | active | Aug 2026 |
| Diovan 320 mg Tablets** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Feb 2026 |
| Diovan 160 mg** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Jan 2026 |
| Diovan 80 mg Tablets** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Dec 2025 |
| VALSAR-DENK 80MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2025 |
| VALSAR-DENK 160MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2025 |
| TAREG 80MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Dec 2024 |
| ADCOTAN 40 | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2024 |
| ADCOTAN 160 | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2024 |
| ADCOTAN 80 | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2024 |
| VALSARTAN_80 80MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| VALSARTAN_160 160MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
Showing 50 of 182 registrations. Sign up free to search and export all.
VALSARTAN in Africa — Regulatory Overview
VALSARTAN is registered across 13 African markets with 182 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Côte d'Ivoire, Nigeria and 9 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 182 registrations, 120 (66%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.